BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 37808520)

  • 1. Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid.
    Li X; Zhong J; Li H; Qiao Y; Mao X; Fan H; Zhong Y; Imani S; Zheng S; Li J
    Front Mol Biosci; 2023; 10():1260883. PubMed ID: 37808520
    [No Abstract]   [Full Text] [Related]  

  • 2. CRISPR-cas technology: A key approach for SARS-CoV-2 detection.
    Fang L; Yang L; Han M; Xu H; Ding W; Dong X
    Front Bioeng Biotechnol; 2023; 11():1158672. PubMed ID: 37214290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets.
    Su W; Li J; Ji C; Chen C; Wang Y; Dai H; Li F; Liu P
    Nano Res; 2023 Mar; ():1-14. PubMed ID: 37359078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on the Mechanism and Applications of CRISPR/Cas9/Cas12/Cas13/Cas14 Proteins Utilized for Genome Engineering.
    Hillary VE; Ceasar SA
    Mol Biotechnol; 2023 Mar; 65(3):311-325. PubMed ID: 36163606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.
    Feng W; Newbigging AM; Tao J; Cao Y; Peng H; Le C; Wu J; Pang B; Li J; Tyrrell DL; Zhang H; Le XC
    Chem Sci; 2021 Mar; 12(13):4683-4698. PubMed ID: 34163728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives.
    Huang T; Zhang R; Li J
    J Adv Res; 2023 Aug; 50():69-82. PubMed ID: 36367481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of CRISPR-Mediated Nucleic Acid Detection Technologies and Their Applications in the Livestock Industry.
    Zhang X
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
    Tan JJ; Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
    Fu R; Xianyu Y
    Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
    Liu L; Pei DS
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of CRISPR/Cas systems in the nucleic acid detection of pathogens: a review].
    Li M; Qin Z; Yin K; Zheng B
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Feb; 35(1):98-103. PubMed ID: 36974023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Molecular Diagnostics Development by CRISPR/Cas Tool: Rapid Detection and Surveillance of Viral Disease Outbreaks.
    Srivastava S; Upadhyay DJ; Srivastava A
    Front Mol Biosci; 2020; 7():582499. PubMed ID: 33425987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges.
    Zhou J; Li Z; Seun Olajide J; Wang G
    Heliyon; 2024 Feb; 10(4):e26179. PubMed ID: 38390187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress of CRISPR-based programmable RNA manipulation and detection.
    Wang B; Yang H
    Wiley Interdiscip Rev RNA; 2023; 14(6):e1804. PubMed ID: 37282821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural principles of CRISPR-Cas enzymes used in nucleic acid detection.
    Das A; Goswami HN; Whyms CT; Sridhara S; Li H
    J Struct Biol; 2022 Mar; 214(1):107838. PubMed ID: 35123001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The era of Cas12 and Cas13 CRISPR-based disease diagnosis.
    Singh M; Bindal G; Misra CS; Rath D
    Crit Rev Microbiol; 2022 Nov; 48(6):714-729. PubMed ID: 35164636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
    Aman R; Mahas A; Mahfouz M
    ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.